Broadwing Bio
PrivateLast Round
Convertible Debt
Feb 2, 2024
Total Funding Raised
$9.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Broadwing Bio is a biotechnology company that develops targeted antibody therapies for the treatment of ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Broadwing Bio Comparables
Compare Broadwing Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galimedix Therapeutics | 79% | |
| Annexon Biosciences | 77% | |
| ONL Therapeutics | 74% | |
Broadwing Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Feb 2, 2024 | ||||
| Corporate Funding | Dec 7, 2020 |
Broadwing Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Echo Investment Capital | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 238% MoM.
- Feb 2, 2024
$10M raised from Echo Investment Capital and others.
Broadwing Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Broadwing Bio's valuation, stock price, and market status.